reviewJournal of Clinical OncologyDec 15, 2004Closed access

Role of VHL Gene Mutation in Human Cancer

Howard Hughes Medical Institute · Dana-Farber Brigham Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

Germline inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene causes the von Hippel-Lindau hereditary cancer syndrome, and somatic mutations of this gene have been linked to the development of sporadic hemangioblastomas and clear-cell renal carcinomas. The VHL tumor suppressor protein (pVHL), through its oxygen-dependent polyubiquitylation of hypoxia-inducible factor (HIF), plays a central role in the mammalian oxygen-sensing pathway. This interaction between pVHL and HIF is governed by post-translational prolyl hydroxylation of HIF in the presence of oxygen by a conserved family of Egl-nine (EGLN) enzymes. In the absence of pVHL, HIF becomes stabilized and is free to induce the expression of its…

Citation impact

936
total citations
FWCI
21.74
Percentile
100%
References
181
Citations per year

Authors

2

Topics & keywords

Keywords
  • Cancer research
  • Angiogenesis
  • Somatic cell
  • Hypoxia-inducible factors
  • Germline mutation
  • Tumor suppressor gene
  • Germline
  • Biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.